These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7400950)

  • 1. Stability of apomorphine in solutions containing ascorbic acid and bisulfite and effects of antioxidants on apomorphine-induced cage climbing and hypothermia in mice.
    Wilcox RE; Humphrey DW; Riffee WH; Smith RV
    J Pharm Sci; 1980 Aug; 69(8):974-6. PubMed ID: 7400950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of multiple dopamine receptors in apomorphine and N-n-propylnorapomorphine-induced climbing and hypothermia.
    Moore NA; Axton MS
    Eur J Pharmacol; 1990 Mar; 178(2):195-201. PubMed ID: 2184043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotypic and hypothermic effects of apomorphine and N-n-propylnorapomorphine in mice.
    Riffee WH; Wilcox RE; Smith RV
    Eur J Pharmacol; 1979 Mar; 54(3):273-7. PubMed ID: 570924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cysteine stability in aqueous amino acid solutions].
    Nekliudov AD; Verem'ëv IV
    Prikl Biokhim Mikrobiol; 1984; 20(3):387-92. PubMed ID: 6431404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photodestabilization of epinephrine by sodium metabisulfite.
    Brustugun J; Tønnesen HH; Klem W; Kjønniksen I
    PDA J Pharm Sci Technol; 2000; 54(2):136-43. PubMed ID: 10822984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonistic activity of ascorbic acid (vitamin C) on dopaminergic modulation: apomorphine-induced stereotypic behavior in mice.
    Deshpande C; Dhir A; Kulkarni SK
    Pharmacology; 2006; 77(1):38-45. PubMed ID: 16569938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleophilic Addition in Aqueous Apomorphine Formulation Solutions in the Presence of Sodium Metabisulfite: Implications for Formulation Development and Manufacturing.
    Sreeramoju MK; Digenis GA
    J Pharm Sci; 2018 Dec; 107(12):3003-3006. PubMed ID: 30114404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on the formulation and admixture of parenteral preparations. I. Degradation of ascorbic acid and cyanocobalamin by sodium bisulfite added to ascorbic acid injection (author's transl)].
    Terao M; Marui E; Tanaka K; Nakao Y
    Yakugaku Zasshi; 1980 Jan; 100(1):81-7. PubMed ID: 7373525
    [No Abstract]   [Full Text] [Related]  

  • 9. Ascorbic acid effect on ethanol sensitivity via possible dopaminergic mediation.
    Yanai J; Fishman RH; Mittleman L
    Subst Alcohol Actions Misuse; 1984; 5(4):169-74. PubMed ID: 6523349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic effects of apomorphine in rats with altered level of brain serotonin.
    Grabowska M; Michaluk J; Antkiewicz L
    Arch Immunol Ther Exp (Warsz); 1975; 23(4):517-26. PubMed ID: 126051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of apomorphine in solutions containing selected antioxidant agents.
    Ang ZY; Boddy M; Liu Y; Sunderland B
    Drug Des Devel Ther; 2016; 10():3253-3265. PubMed ID: 27757015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in the response to apomorphine in rats.
    Masur J; Boerngen R; Tufik S
    Pharmacology; 1980; 20(3):160-5. PubMed ID: 7189886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a novel neurotensin peptide analog given extracranially on CNS behaviors mediated by apomorphine and haloperidol.
    Cusack B; Boules M; Tyler BM; Fauq A; McCormick DJ; Richelson E
    Brain Res; 2000 Feb; 856(1-2):48-54. PubMed ID: 10677610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of enteroviruses by ascorbic acid and sodium bisulfite.
    Salo RJ; Cliver DO
    Appl Environ Microbiol; 1978 Jul; 36(1):68-75. PubMed ID: 29558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose related sequence of effects induced by the DA agonist 2-(N,N-dipropyl)-amino-5,6-dihydroxytetralin.
    Doaré L; Puech AJ; Simon P
    J Pharmacol; 1986; 17(1):60-4. PubMed ID: 3713199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival time in hypoxic mice: differentiation between apomorphine-induced hypothermia and antihypoxic properties.
    Saligaut C; Moore N; Chretien P; Daoust M; Boismare F
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):207-12. PubMed ID: 3724296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of 5-hydroxytryptaminergic antagonists upon apomorphine- and lergotrile-induced hypothermia and stereotyped behaviour in rats.
    Wade RL; Quock RM; Malone MH
    J Pharm Pharmacol; 1984 Oct; 36(10):673-6. PubMed ID: 6150084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further investigations into the relationship between the dopaminergic system, ascorbic acid and uric acid in the rat striatum.
    Desole MS; Miele M; Esposito G; Enrico P; Fresu L; De Natale G; Miele E
    Eur J Pharmacol; 1991 Nov; 205(1):97-100. PubMed ID: 1812002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of chronic chlorpromazine administration or prior treatment with reserpine on brain apomorphine concentrations and apomorphine-induced sterotyped behaviour in the rat.
    Symes AL; Lal S; Young SN; Tsang D; Sourkes TL
    Eur J Pharmacol; 1977 May; 43(2):173-9. PubMed ID: 559575
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in pre- and post-synaptic sensitivity to apomorphine between saline and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57BL/6 mice as reflected in climbing activity.
    Spooren WP; Vassout A; Waldmeier P; Gentsch C
    Eur J Pharmacol; 1998 Jul; 353(1):1-4. PubMed ID: 9721033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.